4.4 Article

Novel phosphatidylinositol 4-kinases III beta (PI4KIIIβ) inhibitors discovered by virtual screening using free energy models

Journal

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
Volume 34, Issue 10, Pages 1091-1103

Publisher

SPRINGER
DOI: 10.1007/s10822-020-00327-9

Keywords

Empirical free energy model; Virtual screening; Lassbio chemical library; PI4KIII beta ligands; Kinase inhibitors

Funding

  1. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (INCT-INOFAR grant) [465.249/2014-0, 309229/2018-9]
  2. CoordenacAo de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001]
  3. FundacAo Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ [E-26/202.146/2015]

Ask authors/readers for more resources

Herein, the LASSBio Chemical Library is presented as a valuable source of compounds for screening to identify hits suitable for subsequent hit-to-lead optimization stages. A feature of the LASSBio Chemical Library worth highlighting is the fact that it is a smart library designed by medicinal chemists with pharmacological activity as the main priority. The great majority of the compounds part of this library have shown in vivo activity in animal models, which is an indication that they possess overall favorable bioavailability properties and, hence, adequate pharmacokinetic profiles. This, in turn, is supported by the fact that approximately 85% of the compounds are compliant with Lipinski's rule of five andca. 95% are compliant with Veber's rules, two important guidelines for oral bioavailability. In this work it is presented a virtual screening methodology combining a pharmacophore-based model and an empirical Gibbs free energy-based model for the ligand-protein interaction to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase III beta (PI4KIII beta) enzyme, which is related to the development of viral infections (including enteroviruses, SARS coronavirus, and hepatitis C virus), cancers and neurological diseases. The approach resulted in the identification of two hits, LASSBio-1799 (7) and LASSBio-1814 (10), which inhibited the target enzyme with IC(50)values of 3.66 mu M and IC(50)and 6.09 mu M, respectively. This study also enabled the determination of the structural requirements for interactions with the active site of PI4KIII beta, demonstrating the importance of both acceptor and donor hydrogen bonding groups for forming interactions with binding site residues Val598 and Lys549.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available